Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Pain|February 1, 1990
Self-administration of morphine in bone marrow transplant patients reduces drug requirementHarlan F Hill, Richard C Chapman, Judy A Kornell, et al.
Vaccine|December 2, 2022
Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditionsKeith M Sullivan, Francis A Farraye, Kevin L Winthrop, et al.
Pain|September 6, 2022
Adjuvanted recombinant zoster vaccine decreases herpes zoster-associated pain and the use of pain medication across 3 randomized, placebo-controlled trialsJoon Hyung Kim, Robert Johnson, Martina Kovac, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|February 23, 2002
Morbidity and mortality of chronic GVHD after hematopoietic stem cell transplantation from HLA-identical siblings for patients with aplastic or refractory anemiasMartin Goerner, Theodore Gooley, Mary E D Flowers, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 30, 2004
Adult recipients of umbilical cord blood transplants after nonmyeloablative preparative regimensNelson J Chao, Liang-Piu Koh, Gwynn D Long, et al.
Hematological Oncology|January 21, 2017
Efficacy and safety of high-dose chemotherapy with autologous stem cell transplantation in senior versus younger adults with newly diagnosed multiple myelomaLi-Wen Huang, Wendi Bacon, Constance Cirrincione, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 22, 2003
Results of minimally toxic nonmyeloablative transplantation in patients with sickle cell anemia and beta-thalassemiaRobert Iannone, James F Casella, Ephraim J Fuchs, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 13, 2017
Manufacture of Autologous CD34<sup>+</sup> Selected Grafts in the NIAID-Sponsored HALT-MS and SCOT Multicenter Clinical Trials for Autoimmune DiseasesCarolyn A Keever-Taylor, Shelly Heimfeld, Kaitlyn C Steinmiller, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 27, 2015
Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell DiseaseMark C Walters, Laura M De Castro, Keith M Sullivan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 26, 2013
Reduced-intensity allogeneic transplantation using alemtuzumab from HLA-matched related, unrelated, or haploidentical related donors for patients with hematologic malignanciesJunya Kanda, Gwynn D Long, Cristina Gasparetto, et al.
Pageof 7